The Businessmeeting took place the 25th of January virtually. There was an important talk about the new WHO 2022 classification of myeloid and lymphoid malignancies highlighting the difference to the new International Consensus Classification, which complexifies the diagnostic work. Find further information on the business meeting in the member area.
